Bethesda, MD | Posted: May 22, 2010
Shuming Nie, the principal investigator of the Emory University and Georgia Institute of Technology Center of Cancer Nanotechnology Excellence, led the research team that developed this new method of characterizing tumor biopsies. The investigators reported their work in the journal ACS Nano. Dr. Nie and his team chose four proteins to target using monoclonal antibodies. To each antibody, they linked a quantum dot - a brightly fluorescent nanoparticle - that emits light with a unique optical signature.
